Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Protein Engineering, Design & Selection : PEDS
|
May 12, 2010
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian R Miller, Stephen J Demarest, Alexey Lugovskoy, et al.
Molecular Cancer Therapeutics
|
August 19, 2010
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response
Jianying Dong, Stephen J Demarest, Arlene Sereno, et al.
Structure (London, England : 1993)
|
March 22, 2016
Computationally Designed Bispecific Antibodies using Negative State Repertoires
Andrew Leaver-Fay, Karen J Froning, Shane Atwell, et al.
Protein Science : a Publication of the Protein Society
|
July 21, 2017
Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
K J Froning, A Leaver-Fay, X Wu, et al.
Mabs
|
March 17, 2015
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
Xiufeng Wu, Arlene J Sereno, Flora Huang, et al.
Biochemistry
|
April 11, 2013
Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines
Stephen J Demarest, Jennifer Gardner, Michelle C Vendel, et al.
Mabs
|
January 12, 2010
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR
Jennifer S Michaelson, Stephen J Demarest, Brian Miller, et al.
Nature Communications
|
May 13, 2020
Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
Karen Froning, Jack Maguire, Arlene Sereno, et al.
Nature Communications
|
May 1, 2025
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study
Anja Koester, Derrick R Witcher, Mark Lee, et al.
Nature Biotechnology
|
January 28, 2014
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M Lewis, Xiufeng Wu, Anna Pustilnik, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Protein Engineering, Design & Selection : PEDS
|
May 12, 2010
Stability engineering of scFvs for the development of bispecific and multivalent antibodies
Brian R Miller, Stephen J Demarest, Alexey Lugovskoy, et al.
Molecular Cancer Therapeutics
|
August 19, 2010
Combination of two insulin-like growth factor-I receptor inhibitory antibodies targeting distinct epitopes leads to an enhanced antitumor response
Jianying Dong, Stephen J Demarest, Arlene Sereno, et al.
Structure (London, England : 1993)
|
March 22, 2016
Computationally Designed Bispecific Antibodies using Negative State Repertoires
Andrew Leaver-Fay, Karen J Froning, Shane Atwell, et al.
Protein Science : a Publication of the Protein Society
|
July 21, 2017
Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies
K J Froning, A Leaver-Fay, X Wu, et al.
Mabs
|
March 17, 2015
Fab-based bispecific antibody formats with robust biophysical properties and biological activity
Xiufeng Wu, Arlene J Sereno, Flora Huang, et al.
Biochemistry
|
April 11, 2013
Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines
Stephen J Demarest, Jennifer Gardner, Michelle C Vendel, et al.
Mabs
|
January 12, 2010
Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTbetaR
Jennifer S Michaelson, Stephen J Demarest, Brian Miller, et al.
Nature Communications
|
May 13, 2020
Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics
Karen Froning, Jack Maguire, Arlene Sereno, et al.
Nature Communications
|
May 1, 2025
Ucenprubart is an agonistic antibody to CD200R with the potential to treat inflammatory skin disease: preclinical development and a phase 1 clinical study
Anja Koester, Derrick R Witcher, Mark Lee, et al.
Nature Biotechnology
|
January 28, 2014
Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface
Steven M Lewis, Xiufeng Wu, Anna Pustilnik, et al.
Page
of 7